Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noelle V Frey

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
American Journal of Hematology|February 21, 2019
Chimeric antigen receptor T cells for acute lymphoblastic leukemiaNoelle V Frey
Hematology. American Society of Hematology. Education Program|December 10, 2021
Relapsed ALL: CAR T vs transplant vs novel therapiesNoelle V Frey
Transplantation and Cellular Therapy|July 3, 2023
Thinking Clearly with AnakinraNoelle V Frey
Transplantation and Cellular Therapy|June 12, 2022
A Bridge To CARNoelle V Frey
Blood|May 4, 2022
Approval of brexucabtagene autoleucel for adults with relapsed and refractory acute lymphocytic leukemiaNoelle V Frey
Hematology. American Society of Hematology. Education Program|December 4, 2016
Cytokine release syndrome with novel therapeutics for acute lymphoblastic leukemiaNoelle V Frey, David L Porter
Best Practice & Research. Clinical Haematology|May 28, 2008
Graft-versus-host disease after donor leukocyte infusions: presentation and managementNoelle V Frey, David L Porter
Blood|May 14, 2015
How I treat adults with relapsed or refractory Philadelphia chromosome-negative acute lymphoblastic leukemiaNoelle V Frey, Selina M Luger
Medical Oncology (Northwood, London, England)|September 13, 2007
The management of posttransplant lymphoproliferative disorderNoelle V Frey, Donald E Tsai
American Journal of Hematology|November 18, 2015
CAR T-cells merge into the fast lane of cancer careNoelle V Frey, David L Porter
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
American Journal of Hematology|February 21, 2019
Chimeric antigen receptor T cells for acute lymphoblastic leukemiaNoelle V Frey
Hematology. American Society of Hematology. Education Program|December 10, 2021
Relapsed ALL: CAR T vs transplant vs novel therapiesNoelle V Frey
Transplantation and Cellular Therapy|July 3, 2023
Thinking Clearly with AnakinraNoelle V Frey
Transplantation and Cellular Therapy|June 12, 2022
A Bridge To CARNoelle V Frey
Blood|May 4, 2022
Approval of brexucabtagene autoleucel for adults with relapsed and refractory acute lymphocytic leukemiaNoelle V Frey
Hematology. American Society of Hematology. Education Program|December 4, 2016
Cytokine release syndrome with novel therapeutics for acute lymphoblastic leukemiaNoelle V Frey, David L Porter
Best Practice & Research. Clinical Haematology|May 28, 2008
Graft-versus-host disease after donor leukocyte infusions: presentation and managementNoelle V Frey, David L Porter
Blood|May 14, 2015
How I treat adults with relapsed or refractory Philadelphia chromosome-negative acute lymphoblastic leukemiaNoelle V Frey, Selina M Luger
Medical Oncology (Northwood, London, England)|September 13, 2007
The management of posttransplant lymphoproliferative disorderNoelle V Frey, Donald E Tsai
American Journal of Hematology|November 18, 2015
CAR T-cells merge into the fast lane of cancer careNoelle V Frey, David L Porter
Pageof 10